Your browser doesn't support javascript.
loading
Zebrafish as a Model to Unveil the Pro-Osteogenic Effects of Boron-Vitamin D3 Synergism.
Sojan, Jerry Maria; Gundappa, Manu Kumar; Carletti, Alessio; Gaspar, Vasco; Gavaia, Paulo; Maradonna, Francesca; Carnevali, Oliana.
Afiliación
  • Sojan JM; Department of Life and Environmental Sciences, Università Politecnica delle Marche, Ancona, Italy.
  • Gundappa MK; The Roslin Institute and Royal (Dick) School of Veterinary Studies, The University of Edinburgh, Midlothian, United Kingdom.
  • Carletti A; Centro de Ciências do Mar (CCMAR), University of Algarve, Faro, Portugal.
  • Gaspar V; Faculty of Medicine and Biomedical Sciences, University of Algarve, Faro, Portugal.
  • Gavaia P; Faculty of Medicine and Biomedical Sciences, University of Algarve, Faro, Portugal.
  • Maradonna F; Centro de Ciências do Mar (CCMAR), University of Algarve, Faro, Portugal.
  • Carnevali O; Faculty of Medicine and Biomedical Sciences, University of Algarve, Faro, Portugal.
Front Nutr ; 9: 868805, 2022.
Article en En | MEDLINE | ID: mdl-35571926
The micronutrient boron (B) plays a key role during the ossification process as suggested by various in vitro and in vivo studies. To deepen our understanding of the molecular mechanism involved in the osteogenicity of B and its possible interaction with vitamin D3 (VD), wild-type AB zebrafish (Danio rerio) were used for morphometric analysis and transcriptomic analysis in addition to taking advantage of the availability of specific zebrafish osteoblast reporter lines. First, osteoactive concentrations of B, VD, and their combinations were established by morphometric analysis of the opercular bone in alizarin red-stained zebrafish larvae exposed to two selected concentrations of B (10 and 100 ng/ml), one concentration of VD (10 pg/ml), and their respective combinations. Bone formation, as measured by opercular bone growth, was significantly increased in the two combination treatments than VD alone. Subsequently, a transcriptomic approach was adopted to unveil the molecular key regulators involved in the synergy. Clustering of differentially expressed genes revealed enrichment toward bone and skeletal functions in the groups co-treated with B and VD. Downstream analysis confirmed mitogen-activated protein kinase as the most regulated pathway by the synergy groups in addition to transforming growth factor-ß signaling, focal adhesion, and calcium signaling. The best-performing synergistic treatment, B at 10 ng/ml and VD at 10 pg/ml, was applied to two zebrafish transgenic lines, Tg(sp7:mCherry) and Tg(bglap:EGFP), at multiple time points to further explore the results of the transcriptomic analysis. The synergistic treatment with B and VD induced enrichment of intermediate (sp7+) osteoblast at 6 and 9 days post fertilization (dpf) and of mature (bglap +) osteoblasts at 15 dpf. The results obtained validate the role of B in VD-dependent control over bone mineralization and can help to widen the spectrum of therapeutic approaches to alleviate pathological conditions caused by VD deficiency by using low concentrations of B as a nutritional additive.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Nutr Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Nutr Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza